• Rayter Z, Chinegwundoh F. An unusual case of omental hernia. Postgraduate
    Medical Journal 1990 66: 682-683.
  • Chinegwundoh FI. The disappearing fax. British Journal of Hospital Medicine
    1991 45:199
  • Chinegwundoh FI, Gough AC, Kaisary AV, Smith DCA, Wolf RC, Spurr NK.
    Debrisoquine metaboliser status as a risk factor for bladder cancer (abstract)
    European Urology, 1992, p.254.
  • Chinegwundoh FI, Gough AC, Kaisary AV, Smith DCA, Wolf RC, Spurr NK.
    Debrisoquine metaboliser status as a risk factor for bladder cancer. Urology
    1992 pages 383-386. ed. Giuliani L, Puppo P. publ. Monduzzi Editore.
  • Chinegwundoh FI. Genoa: BPH discussion , prostate screening and ileal
    segment bladders. Hospital Update 1993 19:14
  • Chinegwundoh FI. Urology Update. Hospital Update 1993 19:614
  • Chinegwundoh FI, Gough AC, Kaisary AV, Smith DCA, Wolf RC, Spurr NK.
    Metabolic oxidative status - a predictor of bladder cancer? The Journal of
    Urology (abstracts) 1993 4:484A
  • Farrar D, Chinegwundoh FI. Urinary Tract Infections. Surgery 1994 12:5,
  • Chinegwundoh FI, Ryan P, Luesley T, Chan S. Renal and diaphragmatic
    endometriosis de novo associated with hormone replacement therapy. J Urol 1995
    153: 380-381.
  • Chinegwundoh FI, Kaisary AV. Smoking, bladder cancer and metabolic
    oxidation. The Journal of Urology, Abstracts from the American Urological
    Association Meeting, May 1994
  • Chinegwundoh FI. Update on Urology. Hospital Update 1994 20: 423
  • Chinegwundoh FI, Nayeem N. Experience of Burch colposuspension in a District
    General Hospital. Br J Clin Prac. 1995 49:41-44
  • Chinegwundoh FI. Recurrent testicular torsion. B J Urol. 1995 76:268
  • Chinegwundoh FI, Kirkham JS. Two cases of volvulus of the stomach associated
    with colon in the chest. Br J Clin Prac. 1995 49:152-153
  • Farrar D, Chinegwundoh FI. How should I deal with recurrent urinary tract
    infection in women. Medicine in Practice 1995 2:11
  • Spurr N, Chinegwundoh FI, Gough A, Smith D. Poymorphisms in drug
    metabolising enzymes as modifiers of cancer risk. Clinical Chemistry 1995
  • Chinegwundoh FI. The post traumatic painful testis. J Roy Soc Med 1996
  • Chinegwundoh FI, French M, Warfield A. Metastatic ureteral tumour. Urologia
    Internationalis 1996 56:55-56
  • Chinegwundoh FI, Kaisary AV. Smoking and polymorphism in bladder cancer. B J
    Urol 1996 77:672-675
  • Chinegwundoh FI. The early history of bladder cancer. Abstract in the
    American Urological Association Meeting book Florida 1996
  • Chinegwundoh FI. Genetic polymorphism and bladder cancer. European Urology
    Abstracts 1996: Vol.30, supplement 2, abstract 286
  • Chinegwundoh FI. Causes of readmission following prostatectomy. European
    Urology Abstracts 1996: Vol.30, supplement 2, abstract 352
  • Chinegwundoh FI. Glutathione s-transferases - responsible for
    chemoresistance? European Urology Abstracts 1996: Vol.30, supplement 2, abstract
  • Chinegwundoh FI. The early history of bladder cancer. European Urology
    Abstracts 1996: Vol.30, supplement 2, abstract 1047
  • Chinegwundoh FI, Khor T, Leedham P. Bladder metastasis from renal cell
    carcinoma BJUrol 1997, 79(4): 650-651
  • Chinegwundoh F I. Letter in the BMJ. December 1997. Surgical waiting lists
  • Chinegwundoh F. I. The Early (Surgical) History of Bladder Cancer. In De
    Historia Urologiae Europaeae volume 4, 1997. Publ. Historical Committee European
    Association of Urology
  • Chinegwundoh FI. Prostate Cancer. Review article in CME Bulletin Geriatric
    Medicine. 1998; 1 (3); 75-77
  • Chinegwundoh F, Oliver T, Farrugia D, Ansell W, Grant-Williams G.
    Intermittent hormone therapy in advanced prostate cancer. Eur Urol 1999:35
    (suppl 2); 1-196, abstr 47
  • Chinegwundoh F, Liyanage G, Oliver T. Screening African-Caribbean versus
    Caucasian Prostate Cancers for markers of enhanced malignancy. Eur Urol 1999:35
    (suppl 2); 1-196, abstr 583
  • Torabi-Pour N, Nouri AME, Chinegwundoh F, Oliver RTD. Standardisation and
    Potential Use of HPLC for Detection of Cellular Placental Alkaline Phosphatase
    Using Established Tumour Cell Lines and Fresh Bladder Biopsies. Urol. Int
  • Farrugia D, Ansell W, Singh M, Philp T, Chinegwundoh F, Oliver RTD.
    Stilboestrol plus adrenal suppression as salvage treatment for patients failing
    treatment with luteinizing hormone-releasing hormone analogues and orchidectomy. BJU International 2000; 85:1069-73
  • Feneley MR, Jan H, Granowski M, Mather SJ, Ellison D, Glass J, Coptcoat M,
    Kirby RS, Ogden C, Oliver RTD, Badenoch DF, Chinegwundoh FI, Nargund VH, Paris AMI, Britton KE. Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer. Prostate Cancer and Prostatic Diseases 2000; 3(1):
  • Iles RS, Right M, Price K, Otite O, Chinegwundoh F, Persad R. Fetal antigen
    2 (FA-2) a new serum marker for the detection and monitoring of patients with bone metastases. Prostate Cancer 2000; 3 (2) poster abstracts p.124
  • Oliver RTD, Farrugia D, Ansell W, Chinegwundoh F. Potential of intermittent
    hormone therapy for M+ and M0 prostate cancer patients. Prostate Cancer and Prostatic Diseases 2000; 3, 1-4
  • Enver MK, Chinegwundoh F, Hoh I. Aspirin and transurethral resection of the
    prostate. European Urology (supplememts 1) 2002, No.1,abstr. 674
  • Chinegwundoh F. Prostate cancer: an update. Caribbean Health 2001; 4 (6):
  • Oliver RTD, Lane T, Wells P, Chinegwundoh F, Nargund V. Medical
    interventions relevant in prevention and management of early prostate cancer: a new potential role for GPs, schools' and works' medical officers, as well as STD, family planning and infertility clinics. Chapter 8 in The Effective
    management of prostate cancer. Edited by Wallace, Oliver, Ash, Miles. Published by Aesculapius medical press, 2002
  • Chinegwundoh F I. Prostate cancer in ethnic
    minorities. Men's health journal, 2003:2 (issue 3); 95-97

  • Chinegwundoh F I, Enver M K, Lee A, Ben-Shlomo Y, Kapoor S, Pati J. Increased risk of prostate cancer in UK African Caribbean immigrants. BJU International, 2003;91, supplement 2, abstract 79

  • Lane TM, Berney D, Chinegwundoh F, Hines J, Philp
    T, Corr J, Oliver T. CGH-based microarrays in the analysis of prostate cancer
    progression from high grade PIN (hgPIN) to hormone resistant and metastatic
    disease. J Urol. 2003; 169(4):58-58 (abstract)

  • Steggall M, Gann Y, Chinegwundoh F. Sexual dysfunction screening: the
    advantages of a culturally sensitive joint assessment clinic. Sexual and
    Relationship Therapy, 2004; 19:179-189
  • Lane TM Ansell W Farrugia D Wilson P Williams G Chinegwundoh F Philp T Hines J Oliver RT. Long-term outcomes in patients with prostate cancer managed with intermittent androgen suppression. Urol Int 2004 ; 73: 117-22 [abstract]
  • Chinegwundoh F, Anie KA. Treatments for priapism in boys and men with sickle cell disease (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd. [abstract]
  • Mohamed K. Enver, Paul D. Miller, Frank I. Chinegwundoh. Upper tract
    surveillance in primary bladder cancer follow-up BJU International Vol. 94
    Issue 6 Page 790 October 2004
  • Thiagarajan Nambirajan, Syed Aslam Sohaib, Christopher Muller-Pollard,
    Rodney Reznek, Frank I. Chinegwundoh. Virtual cystoscopy from computed
    tomography: a pilot study BJU International Vol. 94 Issue 6 Page 828 October
    2004 [abstract]
  • Chinegwundoh F, Lee A, Radhakrishnan S, Hines J, Hill J, Oliver RTD.  Immediate verus deferred radiation for patients receiving intermittent hormone therapy for locally advanced prostate cancer. Br J Urology International, 2005;95, supplement 5, abstract 124, page 91 

  • Thwaini A, Shergill I, Radhakrishnan S, Chinegwundoh F, Thwaini H. Botox in urology. Int Urogynecol J pelvic floor dysfunction. 2005 Nov;19:1-5 [abstract]

  • Steggall M, Gann
    S, Chinegwundoh F. Erectile dysfunction and management at an East London Clinic. J Diabetes Nursing. October 2005

  • Ghani K, Rockall A, Nargund V, Chinegwundoh F.  Prostate biopsy: to stop anticoagulation or not?  BJU Int. 2006 Feb; 97:22-25                                                                                                                                                                 

  • Enver MK, Hoh I, Chinegwundoh F. The management of aspirin in transurethral prostatectomy:current practice in the UK. Ann R Coll Surg Engl 2006; 88:280-283 [abstract]

  • Reichle J, Turk S, Chinegwundoh F, Buchholz N. Prostate stents as ultima ratio in unfit patients. Indian J Urology 2006; 22:68-70

  • Chinegwundoh F, Enver M, Lee A, Nargund V, Oliver T. Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-East London. BJU Int. 2006 Dec. 98:1216-1220 [abstract]

  • Ghani K, Chinegwundoh F. The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2006, 98(3):689-690 [letter]

  • Chinegwundoh F. Management of male stress incontinence. Trends in urology, gynaecology & sexual health 2006; 11(5):12-14 [full text]

  • Stegall M, Gann S, Chinegwundoh F. Management of erectile dysfunction and performance anxiety. Trends in urology, gynaecology & sexual health 2006; 11(5):32-36 [abstract]

  • Otite U, Baithun S, Chinegwundoh F, Nargund V, Iles R. Detection of human chorionic gonadotrophin-β in serum or urine of prostate cancer patients is of no clinical significance. Tumour Biology 2006; 27:181-186 [abstract]

  • Thwaini A, Naase M, Chinegwundoh F, Ghali L, Shergill I, Iles R. Gonadotropins and prostate cancer -revisited. Urologia Internationalis 2006; 77:289-296 [abstract]

  • Stegall M J, Butler J, Coals S, Chinegwundoh F. Heart disease and erectile dysfunction: management at a nurse led clinic. British Journal of Cardiac Nursing 2006, 1 (12):596-601

  • Radhakrishnan S, Lee A, Enver K, Thwaini A, Chinegwundoh F. Impact of
    race on biochemical control after radiotherapy for localised and locally
    advanced prostate cancer. Prostate cancer and prostatic diseases 2006;9:
    abstract on p467

  • Thwaini A, Ghali L, Baithun S, Chinegwundoh F, Ahmed R, Elterifi I, Morgan D, Iles R. HCB beta as a prognostic marker in adenocarcinoma of the prostate in men of multi-ethnic origins. Urology 2006, 68,supplement 5A: p97 abstract

  • Thwaini A, Naase M, Chinegwundoh F, Baithun S, Ahmed R, Morgan D, Richard L, Iles R.  The association between genetic variant of luteinizing hormone and the incidence and prognosis of prostate cancer in groups of multi-ethnic origin. Urology 2006, 68, supplement 5A: p259 abstract UP-02.27

  • Radhakrishnan S, Lee A, Oliver T, Chinegwundoh F. An infectious cause
    for prostate cancer. BJU Int. 2007 Feb. 99(2):239-240

  • Ben-Shlomo Y, Evans S, Metcalfe C, Ibrahim F, Patel B, Gillatt D, Anson K, Corbishley C, Kirby R, Muir G, Chinegwundoh F, Nargund V, Dorling D, Thomas B, Persad R.  The risk of prostate cancer amongst black men in the United Kingdom:the PROCESS cohort study.  European Urology supplement 2007; 6(2):176 abstract no. 616

  • Radhakrishnan S, Chinegwundoh F.  Book chapter - Investigational
    Therapies for prostate cancer in Urological Oncology. Editors: Nargund V,
    Raghavan D and Sandler H. 2008, published by Springer. ISBN-13:978-1846283871

  • Metcalfe Chris; Patel Biral; Evans Simon; Ibrahim Fowzia; Anson Ken; Chinegwundoh Francis; Corbishley Cathy; Dorling Danny; Thomas Bethan; Gillatt David; Kirby Roger; Muir Gordon; Nargund Vinod; Popert Rick; Persad Raj; Ben-Shlomo Yoav; The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. BJU international 2008;102(10):1407-12.

  • Metcalfe C; Evans S; Ibrahim F; Patel B; Anson K; Chinegwundoh F; Corbishley C; Gillatt D; Kirby R; Muir G; Nargund V; Popert R; Persad R; Ben-Shlomo Y; Pathways to diagnosis for Black men and White men found to have
    prostate cancer: the PROCESS cohort study.
       British journal of cancer 2008;99(7):1040-5.

  • Mohammed Aza; Chinegwundoh Frank. Prostatitis syndrome, an overview.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2008;80(3):115-22.

  • Borchert Dietmar H; Sheridan Elizabeth; Papatsoris Athanasios; Zaman Faruquz; Barua Jayanta; Junaid Islam; Pati Jhumur; Buchholz Noor; Chinegwundoh Francis. The case for probiotics in urology. BJU international 2008;101(4):413-4.

  • Ben-Shlomo Yoav; Evans Simon; Ibrahim Fowzia; Patel Biral; Anson Ken; Chinegwundoh Frank; Corbishley Cathy; Dorling Danny; Thomas Bethan; Gillatt David; Kirby Roger; Muir Gordon; Nargund Vinod; Popert Rick; Metcalfe Chris; Persad Raj; The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. European urology 2008;53(1):99-105.

  • Borchert D, Sheridan L, Papatosoris A, Faruqz Z, Barua JM, Junaid I, Pati J, Chinegwundoh F, Buchholz N.  Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J Urology 2008, 24 (2):139-144

  • Ghani K, Oliver R T, Chinegwundoh F.  Human immunodeficiency virus-associated prostate cancer:clinicopathological findings and outcome in a multi-institutional study [letter]. BJUI 2009;103,270-271

  • Chinegwundoh F, Cave G. Book Chapter "Vasectomy" in
    Essential Urology in General Practice.  Editors Araya M, Shergill IS, Silhi N,
    Grange P, Bott S.  2009. Publishers MA Healthcare Ltd. ISBN-13:978 1 85642 372 4

  • Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N.  Prostate cancer disparities in black men of African descent: a comparative literature review of
    prostate cancer burden among black men in the United States, Caribbean, United Kingdom and West Africa.  Infect Agent Cancer 2009, 4 Suppl 1:S2

  • Ben-Shlomo Y, Evans S, Patel B, Anson K, Muir G, Persad R, Metcalfe C, Chinegwundoh F; PROCESS Study Group.  Differences in the epidemiology and presentation of prostate cancer in Black and White men in England: lessons learnt from the process study.  BJU Int. 2009 Mar;103(6):723-4.

  • Mohammed A, Chinegwundoh F.  Testicular varicocele: an overview.  Urol Int.

  • Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Wilson P, Persad R, Ben-Shlomo Y.     Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study.  Br J Cancer. 2010 Jan 19;102(2):249-54.

  • Hameed A, Chinegwundoh F, Thwaini A. Prevention of catheter-related urinary tract infections.  Br J Hosp Med (Lond). 2010 Mar;71(3):148-50, 151-2.

  • Kheirandish P, Chinegwundoh F, Kulkarni S.  Treating stuttering priapism.  BJUI, 2011:108(7);1068-1072, October 2011

  • Kheirandish P, Chinegwundoh F.  An unusual case of triorchidism.  J Roy Soc Med Sh Rep, vol 1 no. 6 55 November 2011     

  • Kheirandish P, Chinegwundoh F. Ethnic differences in prostate cancer. British Journal of Cancer 105, 481-485 (9 August 2011) 

  • Third-Generation Salvage Cryotherapy for Radiorecurrent Prostate Cancer: A Centre’s Experience. Philippou, P, Yap, T, Chinegwundoh, F.
    Urol Int (DOI:10.1159/000332220) Published Online: January 24, 2012 

  • Akhter W, Khan F, Chinegwundoh F. Should every patient with haematospermia be investigated? A crititical review. Central European J Urol. 2013; 66(1):79-82
  • Akhter W, Chinegwundoh F. Role of MRI in the diagnosis of prostate cancer, a proposal. Clincal and Experimental Medical Sciences, vol 1, 2013, no3, 111-116
  • Akhter W, Benton S, Chinegwundoh F. Are PSA, free to total PSA ratio & P2PSA levels helpful to monitor pathological grades of prostate cancer patients on active surveillance. Journal of Endourology. October 2013, 27(S1):P1-A470. Doi:10.1089/end.2013.2001
  • Chinegwundoh F.  The PSA controversy: is overtreatment a price worth paying for earlier diagnosis?  [letter].  Br J Family Medicine July/August 2014; 18
  • MacAttram M, Chinegwundoh F.  Improving Cancer Screening Access for London's African Caribbean Communities living with a diagnosis of mental illness.  Report published in paperback 2014 by Black Mental Health UK & Cancer Black Care.  ISBN 978 0 9929995 0 6
  • Jones A, Chinegwundoh F. Update on prostate cancer in black men within the UK.  ecancer 2014, 8:455 DOI: 10.3332/ecancer.2014.455
  • Oliver T, Blackburn L, Chinegwundoh F. The significance of vitamin D deficiency and anaerobes in prostate cancer.  Cancer Epidemiology Biomarkers and Prevention 10/2015: 24(10 supplement): B89-B89. DOI:10.1158/1538-7755.DISP14 -B89
  • Thakare N, Chinegwundoh F. Prostate cancer in the African Caribbean community.  Trends in Urology and Men's Health 07/2015; 6(4). DOI: 10.1002/tre.472
  • Tilki M, Thompson R, Robinson L, Bruce J, Chan E, Lewis O, Chinegwundoh F, Nelson H.  The BME third sector:marginalised and exploited.  Voluntary Sector Review 2015; vol 6(1): 93-101
  • Ream E, Finnegan-John J, Allchorne P, Pedersen V, Trevatt P, Chinegwundoh F.  Evaluation of a community-based outreach clinic for prostate cancer.  European Journal of Cancer Nursing 09/2014; 18. DOI:10.1016/S1462-3889(14) 70037-7
  • Thakare N, Njoku V, Turk S, Chinegwundoh F.  How are multidisciplinary team decisions implemented in prostate cancer patients?  Poster MP-23.11. Urology 84 (4 supplement 1), October 2014.
  • Thakare N, Chinegwundoh F.  Validation of psa-age volume (PSA-AV) formula for predicting prostate biopsy outcomes in a UK cohort.  Poster published as an abstract in Urology 84 (4 supplement 1), October 2014.
  • Ahmed M, Thakare N, Chinegwundoh F.  Outcomes for transperineal template guided prostate biopsy.  Abstract published in International Journal of Surgery (2015) 23 S15-S134.
  • Bolodeoku J, Bains S, Chand V, Bacon R, Chinegwundoh F. An evaluation of point of care test i-CHROMA prostate specific antigen method for screening in the community. The Journal of Near-Patient Testing & Technology June 2017, 16(2):93-96.
  • Er V, Lane JA, Martin R, Persad R, Chinegwundoh F, Njoku V, Sutton E.  Barriers and facilitators to healthy lifestyles and acceptability of a dietary and physical activity intervention among African Caribbean prostate cancer survivors in the UK: a qualitative study. BMJ Open 2017, vol 7, 10, e017217.
  • Oliver T, Prasher S, Chinegwundoh F, Wilks M. Identification of low oxygen tolerating bacteria in prostate secretions of cancer & suspect cancer patients: aetiological and therapeutic relevance.  The Lancet 390:S71, November 2017.
  • Bamidele O, Mc Garvey H, Lagan B, Ali N, Chinegwundoh F.  Life after prostate cancer: A systematic literature review and thematic synthesis of the post-treatment experiences of Black African and Black Caribbean men.  European Journal of Cancer Care, October 2017.
  • Chinegwundoh F, Smith S, Anie K. Treatments for priapism in boys and men with sickle cell disease. Cochrane database of systematic reviews (online) September 2017.
  • Chinegwundoh F. Urine sample collection: issues and a solution.  Trends urology & Men’s Health 2018, volume 9 issue 1 Jan/Feb 2018.
  • Andrews C, Fortier B……Chinegwundoh F…...  Development, evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate.  Journal of Global Oncology 2018; DOI: 10.1200/JGO.18.00062.
  • Mohammed F, Odedina F, Ibrahim S….. Chinegwundoh F….Okpala I.  Overexpressions of cortisol, annexin V and Lost in expression of PD-L1 and DARC proteins are associated with aggressive prostate cancer phenotypes in Black men: A CaPTC Cohort Study; Cancer Research 78(13)   DOI:10.1158/1538-7445.AM2018-2638.
  • Mohammed F, Odedina…….Chinegwundoh F…..Okpala I.   Cortisol and health-related quality of life as prognostic indicators for prostate cancer risk in West African black men in Nigeria, Cameroon and the USA: the CaPTC Cohort Study.  Cancer health disparities, 2019.
  • Bamidele O, McGarvey H….Chinegwundoh F….McCaughan E.   “Man in the driving seat”: A grounded theory study of the psychosocial experiences of Black African and Black Caribbean men treated for prostate cancer and their partners.  Psycho-Oncology June 2019.
  • Bamidele O, McGarvey H….Chinegwundoh F….McCaughan E.  “Hard to reach, but not out of reach”: Barriers and facilitators to recruiting Black African and Black Caribbean men with prostate cancer and their partners.  European Journal of Cancer Care, December 2018.
  • Beltran L, Leach E, de Fonseka S, Bolodeoku J, Chinegwundoh F. An evaluation of the novel i-CHROMA point of care testing (POCT) method for the analysis of prostate specific antigen (PSA) in serum. Biomed J Sci & Tech Res 9 (4) 2018.
  • Bolodeoku J, Coker O, Bains S, Anyaeche C, Kim K, Chinegwundoh F. The performance of the point of care test (POCT) i-CHROMA PSA method using internal and external quality assessment schemes: United Kingdom External Quality Assessment Service (UKNEQAS) and Randox International Quality Assessment Service (RIQAS). Curr Trends Med Diagn Meth 2018: CTMDM-104. DOI:10.29011/CTMDM-104. 100004.
  • Chinegwundoh F I, Smith S, Anie KA.  Treatments for priapism in boys and men with sickle cell disease.  Cochrane Database Systematic Reviews 2020 April 6;4:CD004198. doi: 10.1002/14651858. CD004198.pub4.
  • Chinegwundoh F, Perera R.  Evaluating psychological support services available for men living with prostate cancer and their carers and families across England.  BJU International 2019 Nov 26. doi: 10.1111/bju. 14959.
  • Chowdhury TA, Khan H, Druce MR, Drake WM, Rajakariar R, Thuraisingham R, Dobbie H, Parvanta L, Chinegwundoh F, Almushatat A, Warrens A, Alstead EM. Flipped learning: Turning medical education upside down. Future Healthcare Journal 2019 Oct;6(3):192-195. doi: 10.7861/fhj.2018-0017.
  • Oliver T, Wilson P, Ansell W, Philp T, Chinegwundoh F, Shamash J, Shaw G, Ahmad A. A prospective audit of intermittent anti-androgen versus pituitary blockade suggests a bipolar androgen type strategy may be safe in untreated prostate cancer. Urol Int. 2018;100(2):172-180. doi: 10.1159/000485255. Epub 2017 Dec22.
  • Chinegwundoh F, Bamigboye E. A case series of a novel phenomenon of ‘whiplash bladder’.  Case studies in surgery vol 5, No. 2 (2019). Doi:https:/
  • Odedina, Folakemi T., Camille C Ragin, Damali N. Martin, Richard P. Moser, Joann S Oliver, Alicia C McDonald, E. L. Rice, Jennifer Nguyen, Frank Chinegwundoh, Belinda Morrinson, Ernest Kaninjing, Mohammed Boie Jalloh and Renee Reams. “Standardized Global Behavioral and Epidemiological Measures for Prostate Cancer Studies in Black Men.” (2019).
  • Fatiregun OA, Chinegwundoh F…….Odedina F.  Quality of Evidence on prostate cancer in Nigeria.  Published 7 May, 2019. Cancer Health.
  • Oliver T, Bhudia R, Chinegwundoh F, Wilks M.  Anaerobes in prostate cancer: new approaches to treatment and prevention.  J Clinical Oncology 2020; volume 38, issue 15 supplement e13606 abstract.
  • Collaborative group research - as part of CRC/BPG UK Familial Prostate Cancer Study Group.
  • Book Chapter: Men’s Health in the Kumar & Clarke Textbook of Clinical Medicine, 10th edition, 2020.
  • Bolodeoku J, Pinkney S, Chand V, Anyaeche C, Kim TK, Chinegwundoh F. Serum total testosterone measurement using point of care test (POCT) I-CHROMA testosterone method in healthy male volunteers.  Research and Reviews Journal of Hospital and Clinical Pharmacy, vol 6, issue 4, pages 1-6, November 2020
  • Jonosky JB, De Villiers N, Wadee R, Chinegwundoh F, Adam A.  (2020). Large bowel obstruction from advanced prostate cancer in a 41-year-old: the role of genetic testing. South African Journal of Surgery58(3), 163.
  • Chinegwundoh, F. (2021). African Organisation for Research & Training in Cancer (AORTIC) at the London Global Cancer Week 15–20 November 2020. Journal of Global Medicine1(1).


  • F. Chinegwundoh.  Time to talk about the risk of prostate cancer risk in black men and what we can do about it.  NHS blog.  12 June 2018.  [accessed 18 April 2021]


  • Potter A, Chinegwundoh F, Vlaev I.  Can targeting women with behavioural science ‘nudges’ help black men to find out more about their high risk of contracting prostate cancer.  Patient Education and Counselling, Volume 104, issue 10, October 2021: pages 2532-2535



  • Grey A, Scott R…Chinegwundoh F…Ahmed H, The CADMUS study group. The CADMUS trial: A paired cohort, blinded study comparing multiparametric ultrasound targeted biopsies with multiparametric MRI targeted biopsies in the detection of clinically significant prostate cancer. J Clinical Oncology (2021); volume 39, issue 15_suppl.:5008


  • Stanway S……….Chinegwundoh F…… Cowan R.  The UK’s contribution to cancer control in low-income and middle-income countries.  The Lancet Oncology, volume 22, issue 9, September 2021, pages e410-e418



  • Martins T, Abel G, Ukoumunne OC, Price S, Lyratzopoulos G, Chinegwundoh F, Hamilton W.  Assessing Ethnic Inequalities in Diagnostic Interval of Common Cancers: A Population-Based UK Cohort Study.  Cancers 2022 June 23; 14(13):3085    [widely reported in the National UK Press August 2022]    Abstract:      PDF Version:


  • Booth C, Chinegwundoh F, Allen S, Van Poppel H.  Diagnosing prostate cancer at a curable stage means providing PSA tests to asymptomatic patients.  BMJ. 2022 Jul 12; 378:o1714.doi:1136/bmj.o1714


  • Tanimola Martins, Gary Abel, Obioha C Ukoumunne, Luke TA Mounce, Sarah Price, Georgios Lyratzopoulos, Frank Chinegwundoh, William Hamilton.  Ethnic inequalities in routes to diagnosis of cancer: a population-based UK cohort study.  Br J Cancer 2022 Sep; 127(5):863-871


  • Chinegwundoh F.  Prostate cancer screening:better outcomes from early detection.  British Medical Journal 2023;382:p1842  Letter published 18 August 2023


  • Caroline Moore .... Chinegwundoh al. Best Current Practice and  Research Priorities in Active Surveillance for Prostate Cancer - a Report of a Movember International Consensus Meeting.  European Urology Oncology. 2023; volume 6, issue 2; p160-182


  • John Bolodeoku, Terry Gbaa, Chidi Anyaeche, Michael Bass, Jonathan Makanjuola, Tae Kyum Kim, and Frank Chinegwundoh.  A correlation and red,amber, green (RAG) analysis of Boditech i-CHROMA prostate specific antigen (PSA) point of care test (POCT) method and ROche PSA laboratory methods.  Journal of Global Medicine 2023,2:113 -